Horizon Kinetics Medical ETF (MEDX) Holdings
MEDX holdings summary
as of Oct 25, 2026- Holdings
- 30 positions listed
- Top 10 weight
- 68.8% of net assets
- Effective holdings
- 11 equal-weight equivalent
- Largest holding
- LLY 19.66% Eli Lilly and Company
- Annual turnover
- 0.0% of the portfolio traded
All MEDX holdings
| # | Name | ||||||
|---|---|---|---|---|---|---|---|
| 1 | LLY | Eli Lilly and Company | Healthcare | 19.66% | $3.4M | $1.12T | 42.2 |
| 2 | ABBV | AbbVie Inc. | Healthcare | 10.26% | $1.8M | $504.37B | 80.6 |
| 3 | NVS | Novartis AG | Healthcare | 6.59% | $1.1M | $286.29B | 22.8 |
| 4 | JNJ | Johnson & Johnson | Healthcare | 5.69% | $990,470.10 | $615.87B | 38.8 |
| 5 | AMGN | Amgen Inc. | Healthcare | 4.86% | $847,351.87 | $233.82B | 26.9 |
| 6 | AZN | AstraZeneca PLC | Healthcare | 4.60% | $800,894.19 | — | — |
| 7 | BMY | Bristol-Myers Squibb Company | Healthcare | 4.53% | $789,292.83 | $122.05B | 13.2 |
| 8 | ALKS | Alkermes plc | Healthcare | 4.48% | $780,374.07 | $6.92B | 108.5 |
| 9 | MRK | Merck & Co., Inc. | Healthcare | 4.37% | $761,090.74 | $360.08B | 115.8 |
| 10 | PFE | Pfizer Inc. | Healthcare | 3.72% | $647,359.13 | $168.60B | 38.9 |
| 11 | BIIB | Biogen Inc. | Healthcare | 3.53% | $614,662.82 | $34.37B | 41.3 |
| 12 | REGN | Regeneron Pharmaceuticals, Inc. | Healthcare | 2.70% | $470,812.98 | $81.41B | 19.6 |
| 13 | GSK | GSK plc | Healthcare | 2.67% | $464,960.04 | $99.19B | 15.6 |
| 14 | IONS | Ionis Pharmaceuticals, Inc. | Healthcare | 2.57% | $448,411.56 | $7.14B | — |
| 15 | ALNY | Alnylam Pharmaceuticals, Inc. | Healthcare | 2.43% | $423,745.61 | $31.02B | 39.1 |
| 16 | CRSP | CRISPR Therapeutics AG | Healthcare | 2.42% | $421,237.21 | $4.76B | — |
| 17 | BEAM | Beam Therapeutics Inc. | Healthcare | 1.08% | $188,217.19 | $2.42B | — |
| 18 | SDZNY | Sandoz Group AG | Healthcare | 0.88% | $153,569.90 | — | — |
| 19 | GALT | Galectin Therapeutics Inc. | Healthcare | 0.81% | $140,836.28 | $365.1M | — |
| 20 | REPL | Replimune Group, Inc. | Healthcare | 0.80% | $140,000.14 | $1.02B | — |
| 21 | NTLA | Intellia Therapeutics, Inc. | Healthcare | 0.69% | $120,751.65 | $1.60B | — |
| 22 | H6D | Haleon PLC | Other | 0.68% | $118,661.31 | — | — |
| 23 | VNDA | Vanda Pharmaceuticals Inc. | Healthcare | 0.46% | $79,990.13 | $243.7M | — |
| 24 | EDIT | Editas Medicine, Inc. | Healthcare | 0.35% | $60,706.79 | $360.9M | — |
| 25 | GEHC | GE HealthCare Technologies Inc. | Healthcare | 0.31% | $54,209.34 | $31.42B | 16.0 |
| 26 | VTRS | Viatris Inc. | Healthcare | 0.31% | $54,069.98 | $21.43B | — |
| 27 | BCYC | Bicycle Therapeutics plc | Healthcare | 0.23% | $39,646.68 | $241.5M | — |
| 28 | ALLO | Allogene Therapeutics, Inc. | Healthcare | 0.11% | $18,691.07 | $452.6M | — |
| 29 | PACB | Pacific Biosciences of California, Inc. | Healthcare | 0.11% | $18,656.23 | $537.7M | — |
| 30 | LTRN | Lantern Pharma Inc. | Healthcare | 0.08% | $14,440.73 | $10.0M | — |
Weights as a percentage of net assets. Value held = weight × net assets ($17.4M). Market cap and P/E from each company's latest fundamentals (U.S.-listed stocks).
MEDX sector breakdown
Sum of the weights of the holdings in each sector.
MEDX top industries
MEDX overlap with other ETFs
| ETF | Fund | Overlap | Shared holdings | Expense ratio |
|---|---|---|---|---|
| PBPH | Portfolio Building Block World Pharma and… | 53.6% | 13 of 52 | — |
| TRUH | VanEck Healthcare TruSector ETF | 44.8% | 11 of 60 | — |
| XLV | Health Care Select Sector SPDR Fund | 44.3% | 11 of 60 | 0.09% |
| IYH | iShares U.S. Healthcare ETF | 43.7% | 13 of 99 | 0.39% |
| DIA | SPDR Dow Jones Industrial Average ETF | 9.6% | 3 of 30 | 0.16% |
| SPY | SPDR S&P 500 ETF | 4.6% | 11 of 502 | 0.09% |
Overlap = sum over shared holdings of the smaller of the two weights. 100% means identical portfolios.
About the MEDX portfolio
Horizon Kinetics Medical ETF holds 30 positions. The ten largest make up 68.8% of the fund, so it behaves like a portfolio of about 11 equally weighted stocks. The biggest positions are Eli Lilly and Company (19.66%), AbbVie Inc. (10.26%), Novartis AG (6.59%), Johnson & Johnson (5.69%), Amgen Inc. (4.86%).
By sector, Healthcare is 91.3%, Other is 0.7%. Holdings data is from the fund's latest portfolio as reported by EODHD on October 25, 2026; positions change as the fund rebalances.
Related: MEDX chart, MEDX performance, MEDX dividends, MEDX valuation, MEDX overview.
MEDX holdings FAQ
How many holdings does MEDX have?
MEDX holds 30 positions as of October 25, 2026.
What are the top 10 holdings of MEDX?
The ten largest holdings are Eli Lilly and Company (19.66%), AbbVie Inc. (10.26%), Novartis AG (6.59%), Johnson & Johnson (5.69%), Amgen Inc. (4.86%), AstraZeneca PLC (4.60%), Bristol-Myers Squibb Company (4.53%), Alkermes plc (4.48%), Merck & Co., Inc. (4.37%), Pfizer Inc. (3.72%). Together they are 68.8% of the fund.
What percentage of MEDX is Eli Lilly and Company?
Eli Lilly and Company is the largest holding at 19.66% of net assets, about $3.4M of the fund's $17.4M.
How concentrated is MEDX?
The top 10 holdings are 68.8% of the fund. By the effective number of holdings (1 divided by the sum of squared weights) MEDX behaves like a portfolio of about 11 equally weighted stocks.